单个神经元的神经退行作为帕金森病退行性模型
Sandro Huenchuguala1, Juan Segura-Aguilar2
1Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Los Carreras, Osorno, Chile.
Neural regeneration research
|September 18, 2023
概括
研究人员提出了帕金森病神经退行症的新模型,建议氨基作为内源性神经毒素. 准像DT-透光酶这样的神经保护酶可能为帕金森病提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 利沃多巴仍然是帕金森病的主要治疗方法,尽管有效性有限,副作用严重.
- 许多临床前候选药物在帕金森病的临床试验中失败了.
- 使用非人类神经毒素的现有动物模型并不准确地反映异常帕金森病的进展.
研究的目的:
- 提出一种新的假设,用于神经退行过程在异常帕金森病.
- 确定一个更相关的内源性神经毒素和一个合适的疾病模型.
- 为帕金森病治疗提出新的治疗点.
主要方法:
- 对现有的帕金森病研究和动物模型进行批判性审查.
- 基于内源性神经毒素机制提出一个假设.
- 确定关键的神经保护酶和通路.
主要成果:
- 提议氨基作为内源性神经毒素,负责异常发病的帕金森病.
- 强调了使用外源神经毒素的现有动物模型的局限性.
- 确定了DT-双酶和谷氨转移酶M2-2作为关键的神经保护酶.
结论:
- 异常性帕金森病可能遵循由氨基染色体启动的单个神经元神经退行模型.
- 激活Keap1/Nrf2通路可以增强神经保护酶的表达.
- 未来的帕金森病疗法应该专注于促进这些保护性酶的分子.
关键词:
1-甲基-4--1-1-甲基-1-甲基-4--1-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-4-甲基-12 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 3 4 4 13 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 5 5 5 5 6 7 7 7 8 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 including including including including including including including including including including including6 - 四胺; 6 - 二多巴胺; 氨基色; 多巴胺神经元; DT - 隔膜酶; 外源神经毒素; 谷氨转移酶 M2-2; 神经黑色素; 帕金森病; 临床前模型.更多相关视频
08:42Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
16.1K
06:17Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
Published on: November 20, 2021
4.2K
相关概念视频
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
